| 1010 |
Large-Core Ischemic Stroke Endovascular Treatment: A Science Advisory From the American Heart Association
|
2024-12-31 |
470 |
| 1009 |
Effect of IV Thrombolysis With Alteplase in Patients With Vessel Occlusion in the WAKE-UP Trial
|
2024-12-31 |
396 |
| 1008 |
Liberal or Restrictive Transfusion Strategy in Aneurysmal Subarachnoid Hemorrhage
|
2024-12-31 |
346 |
| 1007 |
Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation
|
2024-12-03 |
500 |
| 1006 |
Tenecteplase vs Alteplase in Acute Ischemic Stroke Within 4.5 Hours
|
2024-12-03 |
507 |
| 1005 |
Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial
|
2024-12-03 |
561 |
| 1004 |
White Matter Hyperintensities and Cognitive Functions in People With the R544C Variant of the NOTCH3 Gene Without Stroke or Dementia
|
2024-11-01 |
660 |
| 1003 |
Duration of Benefit and Risk of Dual Antiplatelet Therapy up to 72 Hours After Mild Ischemic Stroke and Transient Ischemic Attack
|
2024-11-01 |
705 |
| 1002 |
Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke
|
2024-11-01 |
502 |
| 1001 |
Asundexian versus Apixaban in Patients with Atrial Fibrillation
|
2024-09-27 |
631 |
| 1000 |
Balloon Angioplasty vs Medical Management for Intracranial Artery Stenosis The BASIS Randomized Clinical Trial
|
2024-09-27 |
486 |
| 999 |
Thrombectomy for Stroke With Large Infarct on Noncontrast CT : The TESLA Randomized Clinical Trial
|
2024-09-27 |
655 |
| 998 |
Endovascular Stroke Thrombectomy for Patients With Large Ischemic Core
|
2024-08-28 |
712 |
| 997 |
Efficacy and Safety of High-Dose TBS on Poststroke Upper Extremity Motor Impairment: A Randomized Controlled Trial
|
2024-08-28 |
668 |
| 996 |
Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial
|
2024-08-28 |
592 |
HOME
LOGIN
